Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6712621rdf:typepubmed:Citationlld:pubmed
pubmed-article:6712621lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:6712621lifeskim:mentionsumls-concept:C0014442lld:lifeskim
pubmed-article:6712621lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:6712621lifeskim:mentionsumls-concept:C0026237lld:lifeskim
pubmed-article:6712621lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:6712621lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:6712621lifeskim:mentionsumls-concept:C1442792lld:lifeskim
pubmed-article:6712621lifeskim:mentionsumls-concept:C1705165lld:lifeskim
pubmed-article:6712621lifeskim:mentionsumls-concept:C0085966lld:lifeskim
pubmed-article:6712621lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:6712621lifeskim:mentionsumls-concept:C1510827lld:lifeskim
pubmed-article:6712621lifeskim:mentionsumls-concept:C0205251lld:lifeskim
pubmed-article:6712621lifeskim:mentionsumls-concept:C2700061lld:lifeskim
pubmed-article:6712621lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:6712621pubmed:issue2lld:pubmed
pubmed-article:6712621pubmed:dateCreated1984-5-10lld:pubmed
pubmed-article:6712621pubmed:abstractTextThe degree of inhibition of CPT I (carnitine palmitoyltransferase, EC 2.3.1.21) in isolated rat liver mitochondria by malonyl-CoA was studied by measuring the activity of the enzyme over a short period (15s) after exposure of the mitochondria to malonyl-CoA for different lengths of time. Inhibition of CPT I by malonyl-CoA was markedly time-dependent, and the increase occurred at the same rate in the presence or absence of palmitoyl-CoA (80 microM), and in the presence of carnitine, such that the time-course of acylcarnitine formation deviated markedly from linearity when CPT I activity was measured in the presence of malonyl-CoA over several minutes. The initial rate of increase in degree of inhibition with time was independent of malonyl-CoA concentration. CPT I in mitochondria from 48 h-starved rats had a lower degree of inhibition by malonyl-CoA at zero time, but was equally capable of being sensitized to malonyl-CoA, as judged by an initial rate of increase of inhibition identical with that of the enzyme in mitochondria from fed rats. Double-reciprocal plots for the degree of inhibition produced by different malonyl-CoA concentrations at zero time for the enzyme in mitochondria from fed or starved animals indicated that the enzyme in the latter mitochondria was predominantly in a state with low affinity for malonyl-CoA (concentration required to give 50% inhibition, I0.5 congruent to 10 microM), whereas that in mitochondria from fed rats displayed two distinct sets of affinities: low (congruent to 10 microM) and high (less than 0.3 microM). Plots for mitochondria after incubation for 0.5 or 1 min with malonyl-CoA indicated that the increased sensitivity observed with time was due to a gradual increase in the high-affinity state in both types of mitochondria. These results suggest that the sensitivity of CPT I in rat liver mitochondria in vitro had two components: (i) an instantaneous sensitivity inherent to the enzyme which depends on the nutritional state of the animal from which the mitochondria are isolated, and (ii) a slow, malonyl-CoA-induced, time-dependent increase in sensitivity. It is suggested that the rate of malonyl-CoA-induced sensitization of the enzyme to malonyl-CoA inhibition is limited by a slow first-order process, which occurs after the primary event of interaction of malonyl-CoA with the mitochondria.(ABSTRACT TRUNCATED AT 400 WORDS)lld:pubmed
pubmed-article:6712621pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:languageenglld:pubmed
pubmed-article:6712621pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:citationSubsetIMlld:pubmed
pubmed-article:6712621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712621pubmed:statusMEDLINElld:pubmed
pubmed-article:6712621pubmed:monthMarlld:pubmed
pubmed-article:6712621pubmed:issn0264-6021lld:pubmed
pubmed-article:6712621pubmed:authorpubmed-author:ZammitV AVAlld:pubmed
pubmed-article:6712621pubmed:issnTypePrintlld:pubmed
pubmed-article:6712621pubmed:day1lld:pubmed
pubmed-article:6712621pubmed:volume218lld:pubmed
pubmed-article:6712621pubmed:ownerNLMlld:pubmed
pubmed-article:6712621pubmed:authorsCompleteYlld:pubmed
pubmed-article:6712621pubmed:pagination379-86lld:pubmed
pubmed-article:6712621pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:6712621pubmed:meshHeadingpubmed-meshheading:6712621-...lld:pubmed
pubmed-article:6712621pubmed:meshHeadingpubmed-meshheading:6712621-...lld:pubmed
pubmed-article:6712621pubmed:meshHeadingpubmed-meshheading:6712621-...lld:pubmed
pubmed-article:6712621pubmed:meshHeadingpubmed-meshheading:6712621-...lld:pubmed
pubmed-article:6712621pubmed:meshHeadingpubmed-meshheading:6712621-...lld:pubmed
pubmed-article:6712621pubmed:meshHeadingpubmed-meshheading:6712621-...lld:pubmed
pubmed-article:6712621pubmed:meshHeadingpubmed-meshheading:6712621-...lld:pubmed
pubmed-article:6712621pubmed:meshHeadingpubmed-meshheading:6712621-...lld:pubmed
pubmed-article:6712621pubmed:meshHeadingpubmed-meshheading:6712621-...lld:pubmed
pubmed-article:6712621pubmed:meshHeadingpubmed-meshheading:6712621-...lld:pubmed
pubmed-article:6712621pubmed:meshHeadingpubmed-meshheading:6712621-...lld:pubmed
pubmed-article:6712621pubmed:meshHeadingpubmed-meshheading:6712621-...lld:pubmed
pubmed-article:6712621pubmed:year1984lld:pubmed
pubmed-article:6712621pubmed:articleTitleTime-dependence of inhibition of carnitine palmitoyltransferase I by malonyl-CoA in mitochondria isolated from livers of fed or starved rats. Evidence for transition of the enzyme between states of low and high affinity for malonyl-CoA.lld:pubmed
pubmed-article:6712621pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6712621pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712621lld:pubmed